Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > duH

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Sep 23, 2020 9:29am

160 Views

Post# 31603133

RE:RE:duH

As I thought, just pumping followed by the pumping parrots.

Also, the research should be for BLA "resubmission" getting approved 1 to 2 months from resubmission.

Lets not talk about the original BLA's submitted correctly. Stay focused.

GunnerG wrote: Try to keep up Ernie.

I was asking Eric40 for his link backing up "brought a BLA acceptance very fast, in much less than 6 months, many within in 1 to 2 months from resubmissiom."

DUH is correct.

ernieballs77 wrote: https://www.biospace.com/article/releases/liminal-biosciences-provides-update-on-progress-on-bla-for-ryplazim-and-174-plasminogen-/